Cited by 533Genetic Neurodegenerative DiseasesAutophagy in Disease and TherapyLysosomal Storage Disorders Research

Huntingtin Expression Stimulates Endosomal–Lysosomal Activity, Endosome Tubulation, and Autophagy

Open access
Kegel, Kimberly B., Kim, Manho, Sapp, Ellen, McIntyre, Charmian, Castaño, José G., Aronin, Neil, DiFiglia, Marian·2000·The Journal of Neuroscience

Abstract

An expansion of polyglutamines in the N terminus of huntingtin causes Huntington's disease (HD) and results in the accrual of mutant protein in the nucleus and cytoplasm of affected neurons. How mutant huntingtin causes neurons to die is unclear, but some recent observations suggest that an autophagic process may occur. We showed previously that huntingtin markedly accumulates in endosomal-lysosomal organelles of affected HD neurons and, when exogenously expressed in clonal striatal neurons, huntingtin appears in cytoplasmic vacuoles causing cells to shrink. Here we show that the huntingtin-enriched cytoplasmic vacuoles formed in vitro internalized the lysosomal enzyme cathepsin D in proportion to the polyglutamine-length in huntingtin. Huntingtin-labeled vacuoles displayed the ultrastructural features of early and late autophagosomes (autolysosomes), had little or no overlap with ubiquitin, proteasome, and heat shock protein 70/heat shock cognate 70 immunoreactivities, and altered the arrangement of Golgi membranes, mitochondria, and nuclear membranes. Neurons with excess cytoplasmic huntingtin also exhibited increased tubulation of endosomal membranes. Exogenously expressed human full-length wild-type and mutant huntingtin codistributed with endogenous mouse huntingtin in soluble and membrane fractions, whereas human N-terminal huntingtin products were found only in membrane fractions that contained lysosomal organelles. We speculate that mutant huntingtin accumulation in HD activates the endosomal-lysosomal system, which contributes to huntingtin proteolysis and to an autophagic process of cell death.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.20-19-07268.2000

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CTSD is considered a key protease in the lysosomal degradation of many pathogenic proteins in addition to APP metabolites, including α-synuclein and huntingtin.

    “CTSD is considered as a key protease in the lysosomal degradation of many pathogenic proteins in addition to APP metabolites, including ␣-synuclein and huntingtin (Kegel et al., 2000;Sevlever et al., 2008).”

    From Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99) (2019) · cites this paper as Kegel et al., 2000

    The Abstract reports that huntingtin-containing vacuoles incorporated cathepsin D, and the Discussion proposes the endosomal–lysosomal pathway as a route for huntingtin removal. The paper does not establish that CTSD is a key protease responsible for degrading huntingtin, and it does not address CTSD-mediated degradation of α-synuclein or APP metabolites. Page numbers are unavailable in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 4

  1. Donaldson JG, Lippincott-Schwartz J, Klausner RD (1991) Guanine nu- cleotides modulate the effects of brefeldin A in semipermeable cells: regulation of the association of a 110-kD peripheral membrane protein with the Golgi apparatus. J Cell Biol 112:579 -588.
  2. Evtodienko YV, Teplova VV, Sidash SS, Ichas F, Mazat JP (1996) Microtubule-active drugs suppress the closure of the permeability tran- sition pore in tumor mitochondria. FEBS Letters 393:86 -88.
  3. Lippincott-Schwartz J, Yuan L, Tipper C, Amherdt M, Orci L, Klausner RD (1991) Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67:601-616.
  4. Roizin L, Stellar S, Liu JC (1979) Neuronal nuclear-cytoplasmic changes in Huntington's chorea: electron microscope investigations. In: Advances in neurology, Vol 23 (Chase TN, Wexler NS, Barbeau A, eds), pp 95-122. New York: Raven.

Cited by

Sorted by citations

Authors
Kegel, K. B., Kim, M., Sapp, E., McIntyre, C., Castaño, J. G., Aronin, N., & DiFiglia, M.
Affiliations
  • Massachusetts General Hospital (US)
  • Consejo Superior de Investigaciones Científicas (ES)
Venue
The Journal of Neuroscience
Published
2000-10-01
Volume
20
Issue
19
Pages
7268-7278
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W1940885739
Cited by
533
References
0
Citations by year
2026: 1 · 2025: 19 · 2024: 18 · 2023: 6 · 2022: 11 · 2021: 24 · 2020: 30 · 2019: 18 · 2018: 17 · 2017: 12 · 2016: 27 · 2015: 19 · 2014: 21 · 2013: 26 · 2012: 29
FWCI
9.57
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (T32 AG00222, T32AG000222)
  • National Institute of Neurological Disorders and Stroke (R01NS035711, R01NS038194, P50NS016367)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
Keywords
huntingtin, Huntington's disease, polyglutamine expansion, autophagy, endosomal-lysosomal system, cathepsin D, autophagosomes, autolysosomes, cytoplasmic vacuoles, striatal neurons, neuronal cell death, Golgi membranes
MeSH terms
Huntingtin Protein, Animals, Autophagy, Cathepsin D, Cell Nucleus, Cells, Cultured, Clone Cells, Corpus Striatum, Cytoplasm, Huntington Disease, Hybrid Cells, Lysosomes, Nerve Tissue Proteins, Nuclear Proteins, Peptides, Endosomes, Subcellular Fractions, Transfection, Vacuoles, Blotting, Western, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review